Press Release Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer Telix Pharmaceuticals Limited · Jul 20
Press Release CAREPORTAL ANNOUNCES MILESTONE ACHIEVEMENT: A HALF A MILLION CHILDREN SERVED IN ORGANIZATION’S 11 YEARS Careportal · Jul 20